Ultrasound Obstet Gynecol
Dr. Kamal A. Hamed, MD
- Publications
- 87
- Clinical trials
- 1
- Industry payments
- $13,227
- State license
- 1
- Year NPI issued
- 2008
- Practice address
- NJ
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Hamed's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kamal A. Hamed is an infectious disease specialist in New Jersey
Dr. Hamed practices in New Jersey.
Dr. Hamed's NPI, 1679747844, was assigned on April 17, 2008. Dr. Hamed holds New Jersey license 25MA05391600.
- NPI
- 1679747844NPI Registry (opens in a new tab)
- NPI enumeration date
- April 17, 2008
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dmand AI tracks the EHR system at Dr. Kamal A. Hamed's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamed practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Hamed's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kamal A. Hamed is one of 340 infectious disease specialists in New Jersey
Infectious disease is Dr. Hamed's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Hamed is licensed in New Jersey.
Specialties and state licenses
- Infectious disease, New JerseyPrimary
Infectious disease specialists near Dr. Hamed
Counts of infectious disease specialists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kamal A. Hamed has 87 publications on record
Dmand AI links 87 papers to Dr. Hamed, published from 2012 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Anti-Bacterial Agents, Antimalarials and Cephalosporins. Dr. Hamed has published most often in Antimicrob Agents Chemother. Dr. Hamed's most frequent co-authors are David Alan Melnick, MD, Paul B. Eckburg, MD and Vance G. Fowler, MD.
Dr. Hamed's papers by year, 2016 to 2025
Topics Dr. Hamed writes about most
- Anti-Bacterial Agents
- Antimalarials
- Cephalosporins
- Malaria, Falciparum
- Artemisinins
- Microbial Sensitivity Tests
- Daptomycin
- Ethanolamines
Dr. Hamed's most frequent co-authors
- David Alan Melnick, MD3 shared papers
- Paul B. Eckburg, MD2 shared papers
- Vance G. Fowler, MD2 shared papers
Recent publications by Dr. Hamed
Antimicrob Agents Chemother
Expert Rev Respir Med
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720 (opens in a new tab)
Expert Rev Anti Infect Ther
See who Dr. Hamed researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Hamed works with, so you can find a warm path to the right infectious disease specialists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kamal A. Hamed has worked on 1 clinical trial
Dmand AI links Dr. Hamed to 1 clinical trial. Conditions studied include Invasive Fungal Infections and Mycoses. Open Payments lists research payments to Dr. Hamed that name 1 trial.
Conditions in Dr. Hamed's trials
- Invasive Fungal Infections
- Mycoses
Investigators on the most trials with Dr. Hamed
Recent clinical trials with Dr. Hamed
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kamal A. Hamed received $13,227 in industry payments from 2024 to 2025
CMS Open Payments shows 10 general payments to Dr. Hamed from 2 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 91% of the total. La Jolla Pharmaceutical Company paid the most, $12,100. It also lists 2 research payments totaling $588 in 2020, naming 1 clinical trial.
General payments to Dr. Hamed by program year, 2024 to 2025
General payments to Dr. Hamed by kind, 2024 to 2025
- Consulting fees$12,10091%
- Travel and lodging$1,0858%
- Food and beverage$430%
Companies that paid Dr. Hamed the most, 2024 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Kamal A. Hamed's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kamal A. Hamed
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kamal A. Hamed's NPI number?
Dr. Kamal A. Hamed's NPI number is 1679747844. It was assigned on April 17, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Kamal A. Hamed?
Dr. Kamal A. Hamed is an infectious disease specialist in New Jersey. The primary specialty in the NPI Registry is Infectious Disease Physician (taxonomy code 207RI0200X).
What is Dr. Kamal A. Hamed's medical license number?
Dr. Hamed holds New Jersey license 25MA05391600.
Has Dr. Kamal A. Hamed received payments from drug or device companies?
CMS Open Payments shows $13,227 in general payments to Dr. Hamed from 2 companies from 2024 to 2025. The largest total came from La Jolla Pharmaceutical Company.
How long has Dr. Kamal A. Hamed been practicing?
Dr. Hamed's NPI was assigned in 2008.
Does Dr. Kamal A. Hamed do research?
Dmand AI links 87 publications to Dr. Hamed, published from 2012 to 2025. Dr. Hamed has worked on 1 clinical trial.
Who does Dr. Kamal A. Hamed publish with?
Dr. Hamed's most frequent co-authors are David Alan Melnick, MD (3 shared papers), Paul B. Eckburg, MD (2 shared papers) and Vance G. Fowler, MD (2 shared papers).
Selling to infectious disease practices?
See infectious disease specialists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card